ClinicalTrials.gg
Not yet recruitingNCT07568353Updated Nov 9, 2026

Brain Connectivity and Perceptive Surfaces in Chronic Low Back Pain (SUPER-RMNf)

An interventional study of Perceptive Surface (SU-PER mat) in Low Back Pain and Healthy, sponsored by G. d'Annunzio University. Not yet recruiting at 1 site in Italy. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by G. d'Annunzio University · Not applicable, Interventional, and Basic science

Updated Nov 9, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Non-randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

Rationale:

Chronic Low Back Pain (CLBP) is often associated with "cortical reorganization," where the brain's map of the back becomes less precise. This phenomenon contributes to the persistence of pain and reduced body awareness. While traditional rehabilitation focuses on the physical structure of the spine, neurocognitive approaches use "perceptive surfaces" to provide specific tactile and proprioceptive feedback, aiming to "retrain" the brain's representation of the trunk.

Objective and Hypothesis:

The primary goal of this study is to investigate how the brain responds to stimulation from these perceptive surfaces in patients with CLBP compared to healthy individuals. The investigators hypothesize that using these surfaces will lead to immediate changes in functional brain connectivity, particularly in areas responsible for body awareness and pain processing (somatosensory and salience networks).

Study Procedures:

The study will involve 20 patients with chronic non-specific low back pain and 20 healthy volunteers. All participants will undergo a Functional Magnetic Resonance Imaging (fMRI) session. During the scan, participants will be placed on a specialized perceptive surface. Brain activity and connectivity will be measured at rest and during specific tactile stimulation. Additionally, advanced imaging techniques (SANDI model) will be used to look at the microscopic structure of brain cells (neurons).

Clinical Impact:

By comparing the two groups, the study aims to identify specific "brain signatures" of recovery. This could help clinical professionals understand if perceptive surfaces can effectively restore cortical maps, leading to better personalized rehabilitation strategies for chronic pain.

02

Conditions studied

  • Low Back Pain
  • Healthy

Browse trials for

03

In context

Low Back Pain

2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

This study's planned enrollment of 40 is below the median of 60 across 2,364 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

G. d'Annunzio University is the lead sponsor of 67 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18 and 45 years
  • Right-handed dominance
  • Good general health condition
  • Ability to provide written .

For the patient group:

- Clinical diagnosis of non-specific chronic low back pain with a duration of more than 3 months

For the control group:

- Healthy volunteers without a history of chronic pain

Exclusion criteria

Exclusion Criteria:

  • to 3T Magnetic Resonance Imaging, such as pacemakers or non-compatible metallic implants
  • Pregnancy or breastfeeding
  • Presence of significant neurological or psychiatric pathologies
  • Current use of psychoactive medications.
  • Sensory or motor disorders of the lower limbs that prevent interaction with the perceptive surface.
  • Unstable or acute clinical conditions.
  • Inability to remain still during the MRI scanning procedure
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    CLBP Patients

    This arm includes 20 participants with a clinical diagnosis of non-specific chronic low back pain (duration \> 3 months). Participants undergo a clinical and functional evaluation through validated scales (VAS, RMDQ, MPQ, Waddell Index, Zung SAS/SDS, BAQ). The experimental procedure consists of a 3T MRI session including two resting-state fMRI blocks: one in a neutral condition and one while interacting with a "perceptive surface" (postural mat with sensory cones). Advanced microstructural imaging (SANDI model) is also performed.

    Device: Perceptive Surface (SU-PER mat)

  • Active comparator
    Healthy Controls

    This arm includes 20 healthy volunteers, aged 18-45, without history of chronic pain. Participants undergo the same 3T MRI protocol as the clinical group (neutral vs. perceptive surface conditions) to provide a baseline for "normal" cortical representation and connectivity. Clinical evaluations for this group are limited to demographic data and the Visual Analogue Scale (VAS) for pain/discomfort monitoring during the scan.

    Device: Perceptive Surface (SU-PER mat)

Interventions

  • DevicePerceptive Surface (SU-PER mat)

    The intervention consists of a postural mat equipped with sensory cones of varying elastic memory and elasticity. This tool is used as a neurocognitive rehabilitation device designed to restore body perception and postural control. The device is passive, non-magnetic, and made of MRI-compatible latex (inert material). During the fMRI session, the surface is positioned so that the participant, while lying in the scanner, perceives specific plantar or trunk tactile and proprioceptive stimuli.

06

What researchers measure

Primary outcomes

  1. Functional Connectivity Changes in Somatosensory and Salience Networks

    Time frame: Periprocedural

Secondary outcomes

  1. Neuronal Microstructure Mapping (SANDI model)

    Time frame: Periprocedural

  2. Acute Pain Perception (Visual Analogue Scale)

    Minimum Value: 0 Maximum Value: 10 Higher scores mean a worse outcome

    Time frame: Day 1

  3. Functional Disability in CLBP Patients (Roland Morris Disability Questionnaire)

    Minimum Value: 0 Maximum Value: 24 Higher scores mean a worse outcome

    Time frame: Day 1

Other outcomes

  1. Brainstem Connectivity (PAG)

    Time frame: Periprocedural

07

Study locations

1 site
  • ITAB - Istituto di Tecnologie Avanzate Biomediche - Università degli Studi "G. d'Annunzio"
    Chieti, Chieti (CH) 66100, Italy
08

Updates

1 registry update since Sep 25, 2026
Start date
Sep 1, 2026→Dec 1, 2026
Nov 9, 2026
Primary completion
Dec 1, 2026→May 31, 2027
Nov 9, 2026
Study completion
Mar 1, 2027→Jun 30, 2027
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Start date Sep 1, 2026→Dec 1, 2026
    Primary completion Dec 1, 2026→May 31, 2027
    Study completion Mar 1, 2027→Jun 30, 2027

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07568353
Lead sponsor
G. d'Annunzio University
Responsible party
Teresa Paolucci (Associate Professor, G. d'Annunzio University) — Principal investigator
First posted
May 5, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
May 31, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

Teresa Paolucci
Contact
teresa.paolucci@unich.it
+39 3278588219

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion